Cosmetic cross-reference Noindex: medium evidence

Cis-2-Penten-1-Ol

CAS 1576-95-0

Cis-2-Penten-1-Ol (CAS 1576-95-0) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Cis-2-Penten-1-Ol
CAS Number
1576-95-0
UNII
QNC2NB53MJ
InChIKey
BTSIZIIPFNVMHF-ARJAWSKDSA-N
ChEMBL ID
CHEMBL2269088
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Cis-2-Penten-1-Ol used for in pharmaceutical contexts?

Cis-2-Penten-1-Ol (CAS 1576-95-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Cis-2-Penten-1-Ol?

No adverse-event association or SIDER side-effect rows are rendered for Cis-2-Penten-1-Ol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Cis-2-Penten-1-Ol also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for cis-2-Pentenol with EU status "permitted".

What clinical phase is Cis-2-Penten-1-Ol in?

No phase 1-4 clinical development badge is rendered for Cis-2-Penten-1-Ol because the matched compound identifier rows do not contain a max-phase value.